Trends in the rates of resistance of Ureaplasma urealyticum to antibiotics and identification of the mutation site in the quinolone resistance-determining region in Chinese patients

FEMS Microbiology Letters

Volumn 259, Issue 2, 2006, Pages 181-186

  Xie, Xinyou ^a   Zhang, Jun ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Drug resistance; Quinolone resistance determining region (QRDR); Ureaplasma urealyticum

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; DOXYCYCLINE; ERYTHROMYCIN; JOSAMYCIN; OFLOXACIN; PRISTINAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHINA; CHINESE; CONTROLLED STUDY; GENE SEQUENCE; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; UREAPLASMA UREALYTICUM;

ANTI-BACTERIAL AGENTS; BASE SEQUENCE; CHINA; DNA GYRASE; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; GENES, BACTERIAL; HUMANS; MUTATION; TIME FACTORS; UREAPLASMA INFECTIONS; UREAPLASMA UREALYTICUM;

UREAPLASMA UREALYTICUM;

EID: 33744825994     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2006.00239.x     Document Type: Article

References (20)

1. Bebear CM, Charron A, Bove JM, Bebear J Renaudin J 1998 Cloning and nucleotide sequences of the topoisomerase IV parC, and parE genes of Mycoplasma hominis. Antimicrob Agents Chemother 42: 2024 2031.
2. Bebear CM, Renaudin J, Charron A, Renaudin H, Barbeyrac BD, Schaeverbeke T Bebear C 1999 Mutations in the gyrA, parC, and parE genes associated with fluorquinolone resistance in clinical isolates of Mycoplasma hominis. Antimicrob Agents Chemother 43: 954 956.
3. Bebear CM, Renaudin H, Charron A, Gruson D., Lefrancois M Bebear C 2000 In vitro activity of Trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized. Antimicrob Agents Chemother 44: 2557 2560.
4. Belland RJ, Morrison SG, Ison C Huang WH 1994 Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone- resistant isolates. Mol Microbiol 14: 371 380.
5. Breines DM, Ouabdesselam S, Ng EY, Tankovic J, Shah S, Soussy CJ Hooper DC 1997 Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV. Antimicrob Agents Chemother 41: 175 179.
6. Cassell GH, Waites KB, Watson HL, Crouse DT Harasawa R 1993 Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns. Clin Microbiol Rev 6: 69 87.
7. Ferrero L, Cameron B, Manse B, Lagneaux D, Crouzet J, Framechon A Blanche F 1994 Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones. Mol Microbiol 13: 641 653.
8. Ferrero L, Cameron B Crouzet J 1995 Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus. Antimicrob Agents Chemother 39: 1554 1558.
9. Gellert M, Mizuuchi K, O'Dea MH Nash HA 1976 DNA gyrase: an enzyme that introduces superhelical turns into DNA. Proc Natl Acad Sci USA 73: 3872 3876.
10. Glass JI, Lefkowita E, Glass JS, Heiner CR, Chen EY Cassell GH 2000 The complete sequence of the mucosal pathogen Ureaplasma urealyticum. Nature 407: 757 762 [Letters to Nature].
11. Heisig P 1996 Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother 40: 879 885.
12. Khodursky AB, Zechiedrich EL Cozzarelli NR 1995 Topoisomerase IV is a target of quinolones in Escherichia coli. Proc Natl Acad Sci USA 92: 11801 11805.
13. Kilic D, Basar MM, Kaygusuz S, Yilmaz E, Basar H Batislam E 2004 Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis. Jpn J Infect Dis 57: 17 20.
14. Kumagai Y, Kato J-I, Hoshino K, Akasaka T, Sato K Ikeda H 1996 Quinolone-resistant mutants of Escherichia coli DNA topoisomerase IV parC gene. Antimicrob Agents Chemother 40: 710 714.
15. Lindback E, Rahman M, Jalal S Wretlind B 2002 Mutations in gyrA, gyrB, parC, and parE in quinolone-resistant strains of Neisseria gonorrhoeae. APMIS 110: 651 657.
16. Pan XS Fisher LM 1996 Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding topoisomerase IV: role in fluoroquinolone resistance. J Bacteriol 178: 4060 4069.
17. Reece RJ Maxwell A 1991 DNA gyrase: structure and function. Crit Rev Biochem Mol Biol 26: 335 375.
18. Tankovic J, Perichon B, Duval J Courvalin P 1996 Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro. Antimicrob Agents Chemother 40: 2505 2510.
19. Yamagashi JI, Kojima T, Oyamada Y, Fujimoto K, Hattori H, Nakamura S Inoue M 1996 Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus. Antimicrob Agents Chemother 40: 1157 1163.
20. Zhang W, Wu Y, Yin W Yu M 2002 Study of isolation of fluoroquinolone- resistant Ureaplasma urealyticum and identification of mutant sites. Chin Med J (Engl) 10: 1573 1575.